✦ LIBER ✦

A case report: Ulcerative colitis, treatment with an antibody against tumor necrosis factor (infliximab), and subsequent liver necrosis

✍ Scribed by Urpo Kinnunen; Martti Färkkilä; Heikki Mäkisalo

Book ID: 119223497
Publisher: Oxford University Press
Year: 2012
Tongue: English
Weight: 505 KB
Volume: 6
Category: Article
ISSN: 1873-9946
DOI: 10.1016/j.crohns.2012.02.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A case of ulcerative colitis complicatin

A case of ulcerative colitis complicating anti-tumor necrosis factor treatment for rheumatoid arthritis: successful treatment with leukocytapheresis

✍ Hideyuki Horikoshi; Kunio Takada; Tomoaki Higuchi; Takahiro Yoshikawa; Mitsuyo M 📂 Article 📅 2012 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 302 KB

PGI5 Treatment Patterns of Medicare Pati

PGI5 Treatment Patterns of Medicare Patients with Ulcerative Colitis Initiating Tumor Necrosis Factor Therapy: Application of a Data Visualization Tool

✍ O. Baser; L. Wang; L. Xie; H. Yuce 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Guillain–Barrè syndrome after treatment

Guillain–Barrè syndrome after treatment with human anti-tumor necrosis factorα (adalimumab) in a Crohn's disease patient: Case report and literature review

✍ Monica Cesarini; Erika Angelucci; Tiziana Foglietta; Piero Vernia 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 175 KB

Assessment of antibodies to double-stran

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α: Findings in open-label and randomized placebo-controlled trials

✍ P. J. Charles; R. J. T. Smeenk; J. De Jong; M. Feldmann; R. N. Maini 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 2 views

Objective. To compare the incidence of antidouble-stranded DNA (anti-dsDNA) antibodies in rheumatoid arthritis (RA) patients receiving either single or multiple doses of a chimeric anti-tumor necrosis factor ␣ (anti-TNF␣) antibody or placebo infusions, with or without methotrexate, in open-label, ra

Treatment with monoclonal anti–tumor nec

Treatment with monoclonal anti–tumor necrosis factor α antibody results in an accumulation of Th1 CD4+ T cells in the peripheral blood of patients with rheumatoid arthritis

✍ Madelon M. Maurice; Wiebo L. Van Der Graaff; Angela Leow; Ferdinand C. Breedveld 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 1 views